AVAX eyes an 85-90% rally to $20 as institutional adoption from firms like New York Life and Aave bolsters the network's fundamental outlook.
AVAX surged 50% in a week and is targeting an 85-90% rally to $19-20 based on institutional tokenization catalysts and a bullish technical setup.
Aave is developing an institutional RWA lending market on Avalanche, which could expand its protocol usage.
ICE has been testing Avalanche for a tokenized trading platform but has not announced a commercial deal, so the news is neutral for ICE.
Paxos expanded support for AVAX and USDC, increasing USDC's utility on Avalanche but with no direct price catalyst.
Janus Henderson joined Avalanche as a validator, a minor strategic move with no immediate financial impact.
Avalanche's AVAX token has rallied 50% over the past week to reach eight-month highs of $10.82. The surge is fueled by institutional interest, including tokenized fund launches by New York Life and ongoing testing of the network by Intercontinental Exchange. Technical indicators suggest a potential 85-90% rally toward the $19-20 range as the asset breaks out of a long-term falling wedge pattern.
The surge is primarily driven by institutional tokenization headlines, including New York Life's plan to launch a tokenized fund on Avalanche and ongoing interest from Intercontinental Exchange (ICE) regarding tokenized trading platforms.
AVAX has strong support at the $5.80-$6.50 zone. The next major upside target is $19-$20, which aligns with the upper trendline of its long-term falling wedge and the 0.236 Fibonacci retracement level.